查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1514901

狂犬病疫苗市场，按产品类型、应用、预防类型、最终用户、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Rabies Vaccine Market, By Product Type, By Application, By Prophylaxis Type, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 367 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2023年狂犬病疫苗市场规模为13.4543亿美元，2024年至2032年复合年增长率为4.5%。

狂犬病疫苗市场-市场动态

宠物数量的增加和兽医护理的相应增加强调了宠物疫苗接种的必要性

饲养宠物的趋势不断增长，加上人们对兽医护理意识的不断增强，凸显了宠物疫苗接种的重要性。随着越来越多的家庭欢迎宠物进入家庭，确保这些动物免受可预防疾病的侵害成为当务之急。疫苗可以保护宠物免受各种严重且可能致命的疾病，例如狂犬病、犬瘟热、细小病毒和猫白血病。据调查，印度有超过3,100万隻宠物狗。房主比租屋者更有可能拥有宠物：58% 的房主养狗，36% 的房主养猫，而租屋者的比例分别为 39% 和 29%。 11% 的印度人至少拥有四隻宠物。随着宠物饲养量的不断增加，重视疫苗接种对于保障宠物及其人类同伴的健康至关重要。定期接种疫苗是负责任的宠物照护的重要组成部分，可确保宠物活得更长、更健康，同时保护公众健康。

狂犬病疫苗市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032）每年将以 4.5% 左右的复合年增长率成长

根据预防类型细分，预计暴露前预防将在 2023 年显示最大的市场份额

从应用细分来看，2023年医院是主导类型

根据应用细分，动物是2023年的主导类型

按地区划分，北美是 2023 年的主要收入来源

狂犬病疫苗市场-細項分析：

全球狂犬病疫苗市场根据产品类型、应用、预防类型、最终用户和地区进行细分。

根据预防类型，市场分为两类：暴露前预防和暴露后预防。暴露前预防提供了长期保护，这减少了在可能接触狂犬病的情况下及时进行暴露后护理的要求。当考虑到暴露后预防的费用时，从长远来看，这种长期保护可能被证明是具有成本效益的。

根据最终用户，市场分为三类：医院、兽医诊所和其他。全球宠物拥有率的提高导致对兽医服务的需求增加，包括狂犬病疫苗接种。兽医诊所为宠物（包括狗和猫）提供的预防性护理包括常规疫苗接种计划。定期加强接种疫苗对于维持免疫力至关重要。加强接种的频率取决于所使用的疫苗和当地法律，但通常范围从每年一次到每三年一次。

狂犬病疫苗市场 - 地理洞察

由于产品引进率高、主要製造商的存在以及政府推广狂犬病疫苗接种的活动，北美是狂犬病疫苗的重要市场。三个主要贡献者是美国、加拿大和墨西哥，其中美国由于其先进的医疗保健系统和高度的意识而处于领先地位。由于广泛使用疫苗作为疾病预防策略以及为医疗保健行业的研究和开发提供有利的环境，北美在市场份额方面处于领先地位。根据美国疾病预防控制中心估计，美国每年与狂犬病检测和预防相关的医疗费用已超过3亿美元。

狂犬病疫苗市场-竞争格局：

赛诺菲（法国）、默克公司、辉瑞公司（美国）、VBI Vaccines Inc.（美国）、CSC Pharmaceuticals International、Bio-Med Pvt.有限公司、巴伐利亚北欧（美国）、索尔维（美国）、Informa plc。 （美国）和其他主要参与者都参与了该市场。为了支持市场的整体成长，这些产业参与者正在实施多种方法，包括产能扩张、併购、合作伙伴关係、新产品开发和收购。此外，在分析期间，主要产业参与者在研发方面的投资不断增加将支持市场扩张。例如，2024 年3 月，作为根除狂犬病持续承诺的一部分，新泽西州拉威市默克公司(Merck & Co., Inc.) 的子公司默克动物保健公司(Merck Animal Health) 向全球兽医局( WVS) 捐赠了NOBIVAC(R) 狂犬病疫苗) 狂犬病任务计画。未来五年，这些捐款将继续支持这个非营利组织的年度狂犬病疫苗需求。

最近的发展：

2024 年 2 月，美国生物技术公司 Replicate Bioscience 公布了积极的初步资料，其自我复製 RNA (srRNA) 狂犬病疫苗 RBI-4000 对狂犬病病毒实现了强烈的免疫反应。

2022 年 3 月，牛津大学和 Ifakara 健康研究所宣布为坦尚尼亚人类志愿者测试新型狂犬病疫苗的 Ib/II 期试验的第一批参与者接种疫苗。

目录

第一章：狂犬病疫苗市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按产品类型分類的狂犬病疫苗市场片段
    • 狂犬病疫苗市场片段（依应用）
    • 按预防类型分類的狂犬病疫苗市场片段
    • 最终用户的狂犬病疫苗市场片段
    • 按国家/地区分類的狂犬病疫苗市场摘要
    • 按地区分類的狂犬病疫苗市场片段
  • 竞争洞察

第 3 章：狂犬病疫苗主要市场趋势

  • 狂犬病疫苗市场驱动因素
    • 市场驱动因素的影响分析
  • 狂犬病疫苗市场限制
    • 市场限制影响分析
  • 狂犬病疫苗市场机会
  • 狂犬病疫苗市场未来趋势

第 4 章：狂犬病疫苗产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：狂犬病疫苗市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：狂犬病疫苗市场格局

  • 2023 年狂犬病疫苗市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：狂犬病疫苗市场 - 依产品类型

  • 概述
    • 按产品类型分類的细分市场占有率分析
    • Vero 细胞狂犬病疫苗
    • 小仓鼠肾 (BHK)
    • 鸡胚细胞狂犬病疫苗
    • 其他的

第 8 章：狂犬病疫苗市场 - 按应用

  • 概述
    • 按应用分類的细分市场占有率分析
    • 人类
    • 动物

第 9 章：狂犬病疫苗市场 - 依预防类型

  • 概述
    • 按预防类型分類的细分市场占有率分析
    • 暴露前预防
    • 暴露后预防

第 10 章：狂犬病疫苗市场 - 按最终用户

  • 概述
    • 按应用分類的细分市场占有率分析
    • 医院
    • 兽医诊所
    • 其他的

第 11 章：狂犬病疫苗市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美狂犬病疫苗主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按产品类型）
    • 北美市场规模和预测（按应用）
    • 北美市场规模和预测（按预防类型）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲狂犬病疫苗主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按产品类型）
    • 欧洲市场规模和预测（按应用）
    • 欧洲市场规模和预测（按预防类型）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区狂犬病疫苗主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（依产品类型）
    • 亚太地区市场规模与预测（按应用）
    • 亚太地区市场规模与预测（依预防类型）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲狂犬病疫苗主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按产品类型）
    • 拉丁美洲市场规模与预测（按应用）
    • 拉丁美洲市场规模与预测（按预防类型）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲狂犬病疫苗主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按产品类型）
    • 中东和非洲市场规模及预测（按应用）
    • 中东和非洲市场规模和预测（按预防类型）
    • 中东和非洲市场规模和预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 12 章：主要供应商分析 - 狂犬病疫苗产业

  • 竞争仪表板
  • 公司简介
    • Serum Institute of India Pvt. Ltd
    • Novartis AG
    • Cadila Pharmaceuticals
    • Merck & Co., Inc.
    • Sanofi
    • ADS Diagnostic Ltd
    • GSK plc
    • Berna Biotech Pharma GmbH
    • AstraZeneca
    • Others

第 13 章：360 度分析师视角

第 14 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV3021

REPORT HIGHLIGHT

Rabies Vaccine Market size was valued at USD 1,345.43 million in 2023, expanding at a CAGR of 4.5% from 2024 to 2032.

Growing pet ownership and the corresponding rise in veterinary care emphasize the need for pet vaccinations, thereby expanding the market. Ongoing research and development leading to improved vaccines with better efficacy, longer protection, and fewer side effects stimulate market demand. Increased awareness about rabies prevention and the importance of vaccination through educational campaigns positively impacts market growth. However, there are concerns over potential side effects and adverse reactions that can deter individuals from getting vaccinated.

Rabies Vaccine Market- Market Dynamics

Growing pet ownership and the corresponding rise in veterinary care emphasize the need for pet vaccinations

The growing trend in pet ownership, coupled with an increasing awareness of veterinary care, underscores the importance of pet vaccinations. As more households welcome pets into their families, ensuring these animals are protected against preventable diseases becomes a top priority. Vaccines protect pets from a variety of serious and potentially fatal diseases, such as rabies, distemper, parvovirus, and feline leukemia. According to the survey, there are over 31 million pet dogs in India. Homeowners are more likely to own pets than renters: 58% of homeowners have a dog and 36% have a cat versus 39% and 29% of renters respectively. 11% of people in India own at least four pets. As pet ownership continues to rise, the emphasis on vaccinations is essential for safeguarding the health of pets and their human companions. Regular vaccinations are a vital component of responsible pet care, ensuring that pets live longer, healthier lives while also protecting public health.

Rabies Vaccine Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.5% over the forecast period (2024-2032)

Based on Prophylaxis Type segmentation, Pre-Exposure Prophylaxis was predicted to show maximum market share in the year 2023

Based on application segmentation, Hospitals were the leading type in 2023

Based on application segmentation, the animal was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Rabies Vaccine Market- Segmentation Analysis:

The Global Rabies Vaccine Market is segmented based on Product Type, Application, Prophylaxis Type, End User, and Region.

The market is divided into two categories based on prophylaxis type: Pre-Exposure Prophylaxis, and Post-Exposure Prophylaxis. Long-term protection is provided by pre-exposure prophylaxis, which lessens the requirement for prompt post-exposure care in the event of a possible rabies exposure. When post-exposure prophylaxis costs are taken into account, this long-term protection may prove to be cost-effective in the long run.

The market is divided into three categories based on end-users: Hospitals, Veterinary clinics, and Others. The increased global pet ownership rate has led to a larger need for veterinary services, including rabies vaccinations. The preventative care that veterinary clinics offer to pets, including dogs and cats, includes routine vaccination programs. Regular booster vaccinations are essential for maintaining immunity. The frequency of boosters depends on the vaccine used and local laws, but it generally ranges from annually to every three years.

Rabies Vaccine Market- Geographical Insights

Due to a high rate of product introductions, the existence of major manufacturers, and government campaigns to promote rabies vaccination, North America is a substantial market for rabies vaccines. Three major contributors are the United States, Canada, and Mexico with the United States leading because of its sophisticated healthcare system and high degree of awareness. North America leads the area in terms of market share due to the widespread use of vaccines as a disease prevention strategy and a conducive environment for research and development in the healthcare industry. According to estimates from the Centres for Disease Prevention and Prevention, the annual health costs in America related to the detection and prevention of rabies have surpassed USD 300 million.

Rabies Vaccine Market- Competitive Landscape:

Sanofi (France), Merck & Co. Inc., Pfizer (USA), VBI Vaccines Inc. (USA), CSC Pharmaceuticals International, Bio-Med Pvt. Ltd., Bavarian Nordic (USA), Solvay (USA), Informa plc. (USA), and other major players are among those involved in the market. To support the market's overall growth, these industry players are implementing several methods, including capacity expansion, mergers and acquisitions, partnerships, new product development, and acquisitions. Additionally, during the analysis period, growing investments made in research & development by the major industry players would support market expansion. For instance, In March 2024, As part of its ongoing commitment to eradicating rabies, Merck Animal Health, a division of Merck & Co., Inc., Rahway, N.J., donated NOBIVAC(R) rabies vaccines to the Worldwide Veterinary Service (WVS) Mission Rabies program. Over the next five years, the donations will continue to support this non-profit organization's annual rabies vaccine requirements.

Recent Developments:

In February 2024, US-based biotech Replicate Bioscience announced positive preliminary data where its self-replicating RNA (srRNA) rabies vaccine, RBI-4000 achieved a strong immune response against the rabies virus.

In March 2022, The University of Oxford and the Ifakara Health Institute announced the vaccination of the first participants in a Phase Ib/II trial testing a novel rabies vaccine in human volunteers in Tanzania.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL RABIES VACCINE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Serum Institute of India Pvt. Ltd

Novartis AG

Cadila Pharmaceuticals

Merck & Co., Inc.

Sanofi

ADS Diagnostic Ltd

GSK plc

Berna Biotech Pharma GmbH

AstraZeneca

Others

GLOBAL RABIES VACCINE MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Vero Cell Rabies Vaccine
  • Baby Hamster Kidney (BHK)
  • Chick Embryo Cell Rabies Vaccine
  • Others

GLOBAL RABIES VACCINE MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Human
  • Animal

GLOBAL RABIES VACCINE MARKET, BY PROPHYLAXIS TYPE - MARKET ANALYSIS, 2019 - 2032

  • Pre-Exposure Prophylaxis
  • Post-Exposure Prophylaxis

GLOBAL RABIES VACCINE MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Veterinary clinics
  • Others

GLOBAL RABIES VACCINE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Rabies Vaccine Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Rabies Vaccine Market Snippet by Product Type
    • 2.1.2. Rabies Vaccine Market Snippet by Application
    • 2.1.3. Rabies Vaccine Market Snippet by Prophylaxis Type
    • 2.1.4. Rabies Vaccine Market Snippet by End User
    • 2.1.5. Rabies Vaccine Market Snippet by Country
    • 2.1.6. Rabies Vaccine Market Snippet by Region
  • 2.2. Competitive Insights

3. Rabies Vaccine Key Market Trends

  • 3.1. Rabies Vaccine Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Rabies Vaccine Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Rabies Vaccine Market Opportunities
  • 3.4. Rabies Vaccine Market Future Trends

4. Rabies Vaccine Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Rabies Vaccine Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Rabies Vaccine Market Landscape

  • 6.1. Rabies Vaccine Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Rabies Vaccine Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2. Vero Cell Rabies Vaccine
    • 7.1.3. Baby Hamster Kidney (BHK)
    • 7.1.4. Chick Embryo Cell Rabies Vaccine
    • 7.1.5. Others

8. Rabies Vaccine Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2. Human
    • 8.1.3. Animal

9. Rabies Vaccine Market - By Prophylaxis Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Prophylaxis Type, 2023 & 2032 (%)
    • 9.1.2. Pre-Exposure Prophylaxis
    • 9.1.3. Post-Exposure Prophylaxis

10. Rabies Vaccine Market - By End User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Veterinary clinics
    • 10.1.4. Others

11. Rabies Vaccine Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Rabies Vaccine Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Rabies Vaccine Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Rabies Vaccine Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Rabies Vaccine Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Rabies Vaccine Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Prophylaxis Type, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Rabies Vaccine Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Serum Institute of India Pvt. Ltd
    • 12.2.2. Novartis AG
    • 12.2.3. Cadila Pharmaceuticals
    • 12.2.4. Merck & Co., Inc.
    • 12.2.5. Sanofi
    • 12.2.6. ADS Diagnostic Ltd
    • 12.2.7. GSK plc
    • 12.2.8. Berna Biotech Pharma GmbH
    • 12.2.9. AstraZeneca
    • 12.2.10. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Rabies Vaccine Market: Product Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Rabies Vaccine Market, by Product Type 2019-2032 (USD Million)
  • TABLE Rabies Vaccine Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Rabies Vaccine Market, by Application 2019-2032 (USD Million)
  • TABLE Rabies Vaccine Market: Prophylaxis Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Prophylaxis Type
  • TABLE Global Rabies Vaccine Market, by Prophylaxis Type 2019-2032 (USD Million)
  • TABLE Rabies Vaccine Market: End User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Rabies Vaccine Market, by End User 2019-2032 (USD Million)
  • TABLE Rabies Vaccine Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Rabies Vaccine Market, by Region 2019-2032 (USD Million)
  • TABLE North America Rabies Vaccine Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Rabies Vaccine Market, by Product Type, 2019-2032 (USD Million)
  • TABLE North America Rabies Vaccine Market, by Application, 2019-2032 (USD Million)
  • TABLE North America Rabies Vaccine Market, by Prophylaxis Type, 2019-2032 (USD Million)
  • TABLE North America Rabies Vaccine Market, by End User, 2019-2032 (USD Million)
  • TABLE Europe Rabies Vaccine Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Rabies Vaccine Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Europe Rabies Vaccine Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Rabies Vaccine Market, by Prophylaxis Type, 2019-2032 (USD Million)
  • TABLE Europe Rabies Vaccine Market, by End User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Rabies Vaccine Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Rabies Vaccine Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Rabies Vaccine Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Rabies Vaccine Market, by Prophylaxis Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Rabies Vaccine Market, by End User, 2019-2032 (USD Million)
  • TABLE Latin America Rabies Vaccine Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Rabies Vaccine Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Latin America Rabies Vaccine Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Rabies Vaccine Market, by Prophylaxis Type, 2019-2032 (USD Million)
  • TABLE Latin America Rabies Vaccine Market, by End User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Rabies Vaccine Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Rabies Vaccine Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Rabies Vaccine Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Rabies Vaccine Market, by Prophylaxis Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Rabies Vaccine Market, by End User, 2019-2032 (USD Million)

List of Figures

  • FIGURE Rabies Vaccine Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Product Type segment market share analysis, 2023 & 2032
  • FIGURE Product Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Application segment market share analysis, 2023 & 2032
  • FIGURE Application segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Prophylaxis Type segment market share analysis, 2023 & 2032
  • FIGURE Prophylaxis Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE End User segment market share analysis, 2023 & 2032
  • FIGURE End User segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Rabies Vaccine Market share and leading players, 2023
  • FIGURE Europe Rabies Vaccine Market share and leading players, 2023
  • FIGURE Asia Pacific Rabies Vaccine Market share and leading players, 2023
  • FIGURE Latin America Rabies Vaccine Market share and leading players, 2023
  • FIGURE Middle East and Africa Rabies Vaccine Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Rabies Vaccine Market share analysis by country, 2023
  • FIGURE Germany Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Rabies Vaccine Market share analysis by country, 2023
  • FIGURE India Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Philippines Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Rabies Vaccine Market share analysis by country, 2023
  • FIGURE Brazil Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Rabies Vaccine Market share analysis by country, 2023
  • FIGURE Saudi Arabia Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Rabies Vaccine Market size, forecast and trend analysis, 2019 to 2032 (USD Million)